Bionomics Ltd.-ADRBNOX
13F holders, Q3 2024 (September 30)9holders −4
2new positions
6sold out
1famous investor
$0.44avg. 13F price*
At the end of Q3 2024, 9 institutions reported holding Bionomics Ltd.-ADR (BNOX) in their 13F filings, down 4 from Q2 2024. 2 opened new positions and 6 sold out. The largest holders were Armistice Capital, LLC ($700K), Lynx1 Capital Management LP ($241K) and Point72 Asset Management ($139K). One famous investor held it Steve Cohen (0.0% of Point72 Asset Management's portfolio).
- Company
- Bionomics Ltd.-ADR
- CUSIP
- 09063M205
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $15K |
| Exits | 6 | $93K |
All 13F filers, Q2 2024 → Q3 2024: 406,887 shares bought and 171,245 shares sold, net +235,642 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Armistice Capital, LLC | 0.02% | Add +29.9% | 1,593,000 | $700K |
| Lynx1 Capital Management LP | 0.09% | Reduce -8.3% | 549,673 | $241K |
| Point72 Asset Management | 0.00% | No change | 316,000 | $139K |
| Susquehanna International Group, LLP | 0.00% | New | 34,138 | $15K |
| Rhumbline Advisers | 0.00% | Add +278.1% | 8,300 | $4K |
| Morgan Stanley | 0.00% | Add +12.6% | 894 | $393 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 303 | $133 |
| Aspire Private Capital, LLC | 0.00% | No change | 200 | $88 |
| JPMorgan Chase & Co. | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is BNOX's weight in each manager's 13F, not the share of Bionomics Ltd.-ADR the manager owns.